Search

Displaying results 6581 - 6590 of 10000 in total
  1. Drug

    Ifidancitinib

    go.drugbank.com/drugs/DB16191
    Investigational

    Ifidancitinib is under investigation in clinical trial NCT03585296 (A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis).

  2. Drug

    Timapiprant

    go.drugbank.com/drugs/DB11900
    Investigational

    OC000459 is under investigation for the treatment of Severe Eosinophilic Asthma. OC000459 has been investigated for the treatment of Bronchial Asthma.

  3. Drug

    LY-2452473

    go.drugbank.com/drugs/DB12573
    Investigational

    Ly2452473 is under investigation for the supportive care of Prostate Cancer. Ly2452473 has been investigated for the treatment of Erectile Dysfunction.

  4. Drug

    CHIR-124

    go.drugbank.com/drugs/DB06852
    Experimental

    CHIR-124 is a potent inhibitor of Chk1 that potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo.

  5. Drug

    Tretazicar

    go.drugbank.com/drugs/DB04253
    Investigational

    Tretazicar is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).

  6. Drug

    Desmethylsertraline

    go.drugbank.com/drugs/DB14071
    Experimental

    Desmethylsertraline is a metabolite of sertraline.

  7. Drug

    Pradefovir

    go.drugbank.com/drugs/DB15550
    Investigational

    Pradefovir is a prodrug of [adefovir].

  8. Drug

    Desfesoterodine

    go.drugbank.com/drugs/DB15578
    Investigational

    Desfesoterodine is a metabolite of [tolterodine].

    Products: TOVEDESO 7 MG RETARDTABL
  9. Drug

    2-(3,4-Dihydroxyphenyl)Acetic Acid

    go.drugbank.com/drugs/DB01702
    Experimental

    A deaminated metabolite of levodopa. [PubChem]

  10. Drug

    LY-294002

    go.drugbank.com/drugs/DB02656
    Experimental

    Specific inhibitor of phosphatidylinositol 3-kinase.